Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

33.84

+0.87 (2.64%)

At close: Feb 27, 2026, 4:00 PM EST

33.60

-0.24 (-0.71%)

After-hours: Feb 27, 2026, 7:55 PM EST

Viking Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,910	3,977	4,484	1,862	721	360
Market Cap Growth	19.68%	-11.32%	140.89%	158.23%	100.31%	-12.38%
Enterprise Value	3,205	3,263	3,555	1,487	567	144
Last Close Price	33.84	35.18	40.24	18.61	9.40	4.60
PB Ratio	6.08	6.22	5.09	5.34	4.96	1.78
P/TBV Ratio	6.12	6.22	5.09	5.34	4.96	1.78
Debt / Equity Ratio	0	0	0.00	0.00	0.01	0
Net Debt / Equity Ratio	-1.10	-1.10	-1.02	-1.04	-1.06	-1.00
Quick Ratio	9.21	9.21	32.93	18.92	7.09	23.02
Current Ratio	9.33	9.33	33.09	19.19	7.61	23.98
Return on Equity (ROE)	-47.34%	-47.34%	-17.90%	-34.79%	-39.67%	-24.65%
Return on Assets (ROA)	-30.28%	-30.28%	-14.77%	-23.47%	-23.19%	-14.90%
Return on Capital Employed (ROCE)	-61.50%	-61.50%	-17.10%	-28.90%	-48.00%	-27.60%
Earnings Yield	-9.20%	-9.04%	-2.45%	-4.61%	-9.55%	-15.28%
Buyback Yield / Dilution	-3.33%	-3.33%	-15.57%	-22.79%	0.47%	-6.34%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q